RBC Life Sciences Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net sales of $7.9 million, an 18% increase over net sales of $6.7 million in the second quarter of 2013. The company reported a net loss of $7,000, or $0.00 per basic and diluted share, compared to a net loss of $147,000, or $0.07 per basic and diluted share, for the same quarter last year. Earnings before income taxes were $9,000 compared to loss before income taxes of $226,000 a year ago. Operating income was $33,000 compared to operating loss of $198,000 a year ago.

For the six months, net sales were $13.6 million, a 10% increase over net sales of $12.4 million in the same period last year. Net loss was $385,000, or $0.17 per basic and diluted share, compared to a net loss of $155,000, or $0.07 per basic and diluted share, in the comparable period in 2013. Loss before income taxes was $509,000 compared to $232,000 a year ago. Operating loss was $459,000 compared to operating loss of $174,000 a year ago.